Literature DB >> 23013089

Protocols, physiology, and trials of hydroxyethyl starch.

Christian von Heymann, Michael Sander, Claudia D Spies.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23013089     DOI: 10.1056/NEJMc1209905

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  [Which fluids does my patient need and when yes, how much?]

Authors:  M Sander
Journal:  Anaesthesist       Date:  2017-03       Impact factor: 1.041

2.  Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial.

Authors:  Rasmus G Müller; Nicolai Haase; Jørn Wetterslev; Anders Perner
Journal:  Intensive Care Med       Date:  2013-09-14       Impact factor: 17.440

3.  Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial.

Authors:  Nicolai Haase; Jørn Wetterslev; Per Winkel; Anders Perner
Journal:  Intensive Care Med       Date:  2013-10-01       Impact factor: 17.440

Review 4.  Choice of fluids in critically ill patients.

Authors:  Claude Martin; Andrea Cortegiani; Cesare Gregoretti; Ignacio Martin-Loeches; Carole Ichai; Marc Leone; Gernot Marx; Sharon Einav
Journal:  BMC Anesthesiol       Date:  2018-12-22       Impact factor: 2.217

5.  Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement.

Authors:  Patrick Meybohm; Hugo Van Aken; Andrea De Gasperi; Stefan De Hert; Giorgio Della Rocca; Armand R J Girbes; Hans Gombotz; Bertrand Guidet; Walter Hasibeder; Markus W Hollmann; Can Ince; Matthias Jacob; Peter Kranke; Sibylle Kozek-Langenecker; Stephan Alexander Loer; Claude Martin; Martin Siegemund; Christian Wunder; Kai Zacharowski
Journal:  Crit Care       Date:  2013-07-26       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.